Sally Styring
Submission Manager, Regulatory Affairs Operations at TG Therapeutics, Inc. - New York, NY, US
Sally Styring's Colleagues at TG Therapeutics, Inc.
Sally Styring's Contact Details
HQ
(212) 554-4484
(212) 554-4484
Location
New York City Metropolitan Area
New York City Metropolitan Area
Company
TG Therapeutics, Inc.
TG Therapeutics, Inc.
Sally Styring's Company Details
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Frequently Asked Questions about Sally Styring
Sally Styring currently works for TG Therapeutics, Inc..
Sally Styring's role at TG Therapeutics, Inc. is Submission Manager, Regulatory Affairs Operations.
Sally Styring's email address is ***@tgtxinc.com. To view Sally Styring's full email address, please signup to ConnectPlex.
Sally Styring works in the BioTech/Drugs industry.
Sally Styring's colleagues at TG Therapeutics, Inc. are Brett Smith, Benjamin Yee, Gregory Yen, John Ventrello, Nate Carsto, Amanda Karlavage, Rui Yu and others.
Sally Styring's phone number is (212) 554-4484